KORU Medical Systems Enters Material Definitive Agreement

TL;DR

KORU Medical Systems signed a big deal on 11/19/25, filing an 8-K.

AI Summary

KORU Medical Systems, Inc. entered into a Material Definitive Agreement on November 19, 2025. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as REPRO MED SYSTEMS INC, is incorporated in Delaware and headquartered in Mahwah, NJ.

Why It Matters

This filing indicates a significant new contract or partnership for KORU Medical Systems, which could impact its future revenue and operations.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.

Key Numbers

• 001-39086 — SEC File Number (Identifies the company's filings with the SEC.)
• 13-3044880 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• KORU Medical Systems, Inc. (company) — Registrant
• November 19, 2025 (date) — Date of earliest event reported
• REPRO MED SYSTEMS INC (company) — Former company name
• Mahwah, NJ (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — nge on which registered common stock, $0.01 par value KRMD The Nasdaq Stock Marke

Filing Documents

• form_8-k.htm (8-K) — 22KB
• ex_10-1.htm (EX-10) — 165KB
• 0001161697-25-000426.txt ( ) — 387KB
• krmd-20251119.xsd (EX-101.SCH) — 3KB
• krmd-20251119_lab.xml (EX-101.LAB) — 33KB
• krmd-20251119_pre.xml (EX-101.PRE) — 22KB
• form_8-k_htm.xml (XML) — 3KB

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement On November 19, 2025, the Company entered into an Amended and Restated Manufacturing and Supply Agreement (the "Agreement") with Command Medical Products, Inc. ("Command"), pursuant to which Command has agreed to manufacture and supply the Company's subassemblies, needle sets and tubing products pursuant to the Company's specifications and purchase orders. The Agreement, which is effective as of January 1, 2024, amends and restates in its entirety the Manufacturing and Supply Agreement entered into between the Company and Command dated November 11, 2020. The Agreement expires by its terms on December 31, 2026, and will automatically renew for successive one-year periods unless one party elects not to renew in accordance with the terms of the Agreement. Either party may terminate the Agreement upon a material breach by the other Party that has not been cured within 45 days, upon the bankruptcy or insolvency of the other party or as otherwise expressly set forth in the Agreement. The Agreement includes specific terms regarding pricing and payment, rebates, and purchase commitments based on the Company's forecast. The Agreement also includes customary provisions relating to, among other things, delivery, inspection procedures, warranties, quality management, business continuity plans, handling and transport, intellectual property, confidentiality and indemnification.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 10.1 Amended and Restated Manufacturing and Supply Agreement effective as of January 1, 2024, entered into on November 19, 2025, between KORU Medical Systems, Inc. and Command Medical Products, Inc. (filed herewith) 104 Cover Page Interactive Data File (embedded within the inline XBRL document) - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORU Medical Systems, Inc. (Registrant) Date: November 25, 2025 By: /s/ Linda Tharby Linda Tharby President and Chief Executive Officer - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR